TFC Financial Management’s Charles River Laboratories CRL Stock Holding History

TFC Financial Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59K	Buy	7 +6	+600%	+$1.07K	﹤0.01%	598
2026 Q1	$173	Hold	1	–	–	﹤0.01%	804
2025 Q4	$200	Hold	1	–	–	﹤0.01%	775
2025 Q3	$157	Hold	1	–	–	﹤0.01%	835
2025 Q2	$152	Sell	1 -2	-67%	-$267	﹤0.01%	823
2025 Q1	$452	Buy	+3	New	+$503	﹤0.01%	660
2024 Q4	–	Sell	-1	Closed	-$197	–	991
2024 Q3	$197	Buy	+1	New	+$208	﹤0.01%	750
2024 Q2	–	Sell	-1	Closed	-$271	–	996
2024 Q1	$271	Buy	+1	New	+$239	﹤0.01%	696

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

TFC Financial Management's CRL Position: Q2 2026 in Review

TFC Financial Management increased its Charles River Laboratories (CRL) stake by 600% in Q2 2026, buying an estimated $1.07K and bringing the position to 7 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #598.

TFC Financial Management first reported a position in CRL in Q1 2024 and has held it in 8 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

TFC Financial Management held 7 shares of Charles River Laboratories worth $1.59K as of Q2 2026.
TFC Financial Management bought 6 Charles River Laboratories shares in Q2 2026, an estimated $1.07K.
Charles River Laboratories made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #598 holding.
TFC Financial Management first reported a position in Charles River Laboratories in Q1 2024 and has held it in 8 quarters since.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.